In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Axsome Therapeutics (AXSM – Research Report), ...
In a report released today, Uy Ear from Mizuho Securities reiterated a Buy rating on Arcutis Biotherapeutics (ARQT – Research Report), with a ...
Securities adjusted its outlook on Albemarle Corporation (NYSE:ALB), a leading producer of lithium, by reducing its price target from $105.00 to $90.00, while keeping a Neutral rating on the stock.
Securities adjusted its outlook on Alphabet Inc. (NASDAQ:GOOGL), reducing the tech giant's price target from $235 to $230, ...
The Japan Fair Trade Commission on April 13 rebuked Mizuho Securities Co. for setting initial public offering (IPO) prices of newly listed stocks too low, which could lead to violating the Anti ...
The news comes on the heels of promising Phase I/Ib data, which point to the potential of casdatifan as a more effective ...
Principal Financial Group Inc. lowered its position in shares of Universal Health Services, Inc. (NYSE:UHS – Free Report) by 5.9% during the fourth quarter, according to its most recent disclosure ...
Allspring Global Investments Holdings LLC decreased its position in NVR, Inc. (NYSE:NVR – Free Report) by 4.2% during the 4th ...
Mizuho Securities analyst Dan Dolev upgraded Coinbase Global (NASDAQ:COIN) shares to Neutral from Underperform on Wednesday on the expectation the crypto exchange will benefit from further gains ...
The S&P 500 notched another record. The Dow and Nasdaq were also higher Wednesday after the stock market reacted to minutes from the Federal Reserve's January meeting.